Clinical trial
Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Nephropathy
NCT00311870 is registered in ClinicalTrials.gov with Steno Diabetes Center Copenhagen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Nephropathy
- Lead sponsor
- Steno Diabetes Center Copenhagen
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 1993
- Completion date
- April 30, 1999
- Enrollment
- 52
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic nephropathy